Founded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and USA, was acquired by Evotec (www.evotec.com) in 2016. The Evotec Group offer expert support from early discovery through to clinical development.
* High-throughput ADME screening
* Customised ADME assays
* In silico ADME predictive modeling
* In vitro toxicology
Company Details
- Employees
- 190
- Founded
- -
- Address
- Block 24, Alderley Park, Alderley Edge,united States
- Phone
- +44 1625 505100
- en****@****tex.com
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- cyprotex.com
- Keywords
- In vitro ADME, In vitro Toxicology, Transporters, Cardiotoxicity, DMPK, Hepatotoxicity, DDI, Neurotoxicity.
- HQ
- Macclesfield, Cheshire
Cyprotex Questions
Cyprotex's helpline number is +44 1625 505100
Cyprotex's website is cyprotex.com
Cyprotex's LinkedIn profile is https://www.linkedin.com/company/cyprotex
Cyprotex has
190 employees.
View email and phone details for 190
employees at Cyprotex.
Cyprotex's industry is
Research Services
Cyprotex's top competitors are
Apconix,
Redx Pharma,
Charles River Laboratories,
Medicines Discovery Catapult,
Aptuit,
Just - Evotec Biologics,
Evotec,
Alderley Analytical Ltd,
Gentronix, Part Of Scantox Group,
Sygnature Discovery.
Cyprotex's support email address is enquiries@cyprotex.com
Cyprotex's categories are Research Services
Cyprotex's founding year is 1999
